Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
Genetic alterations in chronic lymphocytic leukaemia
Authors
Llorenç Coll-Mulet
Joan Gil
Publication date
01-04-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0340-z

Other articles of this Issue 4/2009

Clinical and Translational Oncology 4/2009 Go to the issue

Research Articles

Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis

Reviews

Pralatrexate, a new hope for aggressive T-cell lymphomas?

Case Reports

Retroperitoneal tumour radiotherapy: clinical improvements using kilovoltage cone beam computed tomography

Correspondence

Synchronous isolated adrenal metastasis from rectum adenocarcinoma

Research Articles

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Research Articles

Screening practice and misplaced priorities
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits